DatasetName,DDX54_C(74) DDX54_C(75) DDX54_S(34) DDX54_S(39) DDX54_S(41) DDX54_S(527) DDX54_S(569) DDX54_S(644) DDX54_S(696) DDX54_S(698) DDX54_S(73) DDX54_S(743) DDX54_S(75) DDX54_S(774) DDX54_S(776) DDX54_S(782) DDX54_S(788) DDX54_S(851) DDX54_S(95) DDX54_T(120) DDX54_T(182) DDX54_T(197) DDX54_T(223) DDX54_T(73) DDX54_T(74) DDX54_T(814) DDX54_T(815),DDX54_S(100) DDX54_S(104) DDX54_Y(105)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.539776672518211,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.5393440944276561,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5417712566477036,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5440037077789845,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,0.5441376125458078,
ZX2022_Control Replicate 2,0.531535649453621,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5428756140954678,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5424736767056645,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5422747427635566,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.5410888679700838,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.5429504207851983,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5408102980187225,
WZ2023_Pu_010_30min,0.5372342138417606,
AS2011_Ratio H/L Proteins RNAi_2,0.557296896173043,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5408923676072922,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.545611871685711,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5446737362727707,
JJ2018_Ratio H/L normalized___1,0.537089740069671,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.5398081578198449,
AH2018_SILAC_MR_2_N,0.5448386360709869,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.534559595600428,
AS2011_Ratio H/L Proteins Inhi_2,0.5459069567196652,
BS2014_Log2(Ratio H/L normalized),0.5372269001756023,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5371859328917561,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5356728165720276,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5308412624536625,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5362066636709074,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,0.5513430663232085,
AST2020_anti-CD3+PDL2.1,0.5412865604584062,
KBE2022_Log2_Ex_34_U,0.5441003557400723,
WZ2023_Pu_005_10min,0.5416357398150858,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.539777212319504,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,0.5381446775561978,
WZ2023_Pu_025_30min,0.5422779550186291,
AH2018_SILAC_MR_2_X,0.5392289126510333,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,0.5466786792175338,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5458083469916373,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,0.5399626805061963,
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,0.549949284978929,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5436967771214518,
JJ2018_Ratio M/L normalized pP3,0.537517483012511,
AH2018_SILAC_M_2_N,0.5425010221147928,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.5400000901662302,
AH2018_LFQ_1_C,0.5458926504697493,
AS2011_Ratio H/L Normalized Inhi_1_3,0.5188048506315662,
KBE2022_Log2_Ex_28_T,0.5450391355451162,
HS2024_3_B_N1,0.5414645273124076,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5393948643287501,
CK2022_11 40-1,0.5405211182540884,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5432812253787664,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5555570716385838,
FSO2013_Ratio H/L normalized Rep2,0.5390517822458826,
WZ2023_Pu_005_20min,0.5427377863418292,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5445351794748112,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,0.5293986040097381,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5391297938553213,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,0.5420951919211996,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5471177959855976,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.5371656572724183,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,0.5380608170064282,
CK2022_1 16-1,0.5475004541766519,
CK2022_1 200-1,0.5453765661359632,
PG2020_Intensity Mock_10h_D,0.5221835623786756,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.5362051717299449,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,0.5317104061250002,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5335461915134273,
RCJD2014_5min_1,0.5385445458249629,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,0.5468146110220858,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5392410037177661,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5306319984003769,
KBE2022_Log2_Ex_8_T,0.5458600098734987,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.5484939300572218,
RN2012_L11,0.5360042018495256,
AS2011_Ratio H/L Normalized Inhi_2_2,0.544068553352921,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.5446837076355501,
CK2022_3 40-1,0.5444264847049949,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.5378010446678816,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.538591917147434,
EJN2021_5_Rest_Basal,0.5393985878912735,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,0.541376489717945,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,0.5393285763962159,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5436349676082055,
YA2020_Reporter_intensity_Normal_No.1,0.5374398334607551,
HS2024_3_B_T1,0.5474880760646145,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5396092130723642,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,0.5322235816119778,
GF2025_P7_Sph,0.5418446133116412,
HS2024_8_I_T3,,
CF2017_EOC 3,0.5412378018665386,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,0.5420736944761043,
HS2024_6_PD_T3,0.5411205232637246,
DL2023_12h-2,0.5454925929369814,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5400963576018073,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5447287490779457,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5422712011605705,
KS2014_Intensity N3,0.5390168194221044,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5437788804608235,
FSO2013_Ratio H/M normalized Rep2,0.5368696874987534,
RAM2015_Log2 A,0.547275937850564,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.5410190857207621,
KS2014_Intensity E15_2,0.5515502375574655,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5422636509263828,
AH2018_SILAC_M_3_X,0.5437230910235988,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,0.5110248850760735,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5494928858144751,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5461545376881405,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),0.5535829477431584,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.5414660102580249,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5407877461996956,
HS2024_6_B_N1,0.5396676906396521,
KBE2022_Log2_Ex_27_T,0.542710228132667,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,0.5730318384270142,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.543192464527023,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.5358828299329337,
FSO2013_Ratio M/L normalized Rep2,0.5382076753934913,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.5364854606015139,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.5396832318527923,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.5353655558033381,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5514039547427603,
DL2023_control-1,0.5450344650991352,
AR2021_ALG 10 μM,0.537127519834067,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.544411069258661,
EJN2021_4_Rest_Ins,0.5398270748664159,
RN2012_H05,0.5406392768569116,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5404742333775953,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.5398289416905142,
HH2022_Reporter intensity 3,0.5444826391660214,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5443837671824404,
JW2021_After_3,,
GF2025_P8_Sph,0.5315261274349373,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5424554118201853,
CK2022_11 200-1,0.5430646552620773,
CK2022_12 200-1,0.5420000789446621,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5387712956440337,
WZ2023_Su_010_20min,0.534395651322986,
AH2018_TMTMS2_2_N,0.5471741497745418,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5371437776927,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5392456058528383,
KS2014_Intensity N4,0.5386869677815144,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,0.5450109433949691,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5404559449733205,
CK2022_14 200-1,0.5430882130509441,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5394140853173647,
AST2020_anti-CD3+PDL2.2,0.54144739337437,
PG2020_Intensity Mock_10h_A,0.533544292658542,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.5398292838057503,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5439272170825324,
GF2025_P1_Adh,0.5360988977000395,
GF2025_P1_Sph,0.541664767516465,
EJN2021_5_Ex_Basal,0.5397203347851313,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.541000882166325,
CF2017_EOC 1,0.5435186752218094,
CK2022_3 200-1,0.545303666045646,
AH2018_LFQ_IT_3_C,0.542964074685383,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),0.5370110553106099,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.5378890096358903,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,0.5393347237154628,
HS2024_6_PD_T2,0.5390182862558118,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,0.5461388881385622,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.5474653237098663,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.5441534972928174,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5453803527377685,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5422424573717445,
AR2021_ALG 1 μM,0.5380413285750799,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.539420792335795,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.5501364314048443,
CR2017_Ratio Replicate 3.2,0.5354798329279954,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5486384486760572,
CK2022_9 16-1,0.5447221591308772,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,0.5587793714836091,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5430442758834041,
AS2011_Ratio H/L Normalized_2,0.5468988852123281,
PG2020_Intensity 6h_D,0.5266644957551885,
CK2022_16 16-1,0.5427803337169131,
FS2019_db/db3,,
CK2022_15 40-1,0.53920560336553,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5409512461703521,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),0.5434974465124479,
KBE2022_Log2_Ex_41_T,0.5376250091215233,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5432754367371394,
HS2024_5_PD_T3,0.5467108522669883,
AH2018_TMTMS3_3_X,0.5365799975809905,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.54500522969016,
AH2018_LFQ_M_1_N,0.5268307148491315,
KBE2022_Log2_Ex_27_U,0.5398401213004611,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5439551346065191,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.539149390464144,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5363971225068986,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5426390814698001,
RN2012_L13,0.5401774029021249,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.5367277823380644,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.5482014093958083,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,0.5168678268784611,
FSO2013_Ratio H/M normalized Rep2___1,0.5376110479103056,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.5407635032185039,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5278254265559134,
HH2022_Reporter intensity 6,0.5390800982688996,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,0.5367572864806895,
AS2011_Ratio H/L Normalized RNAi_2_2,0.5580470926066136,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5375420733590082,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5452548628401886,
GF2025_P3_Adh,0.5363202333158744,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5472225297222852,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5395860389160689,
KBE2022_Log2_Ex_19_U,0.5507714322445384,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,0.5393570346445437,
YA2020_Reporter_intensity_Cancer_No.1,0.5378080112593889,
AST2020_Control,0.5404726295047676,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.533859357883713,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,0.5188048506315662,
FSO2013_Ratio M/L normalized Rep2___1,0.5383451394436949,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.5387362559172378,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.5452516543400081,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.5305075092309403,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5408585371227289,
HH2022_Reporter intensity 1,0.5407785126793399,
HH2022_Reporter intensity 2,0.5443346478203257,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5380461866185623,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.535467097327127,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.541297385889158,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5387916190201137,
AR2021_KD 72h,0.526158839241652,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5407684884498893,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5383499560251953,
KBE2022_Log2_Ex_9_U,0.5528316853610667,
AH2018_SILAC_M_3_N,0.5436075262328073,
KBE2022_Log2_Ex_13_T,0.5503403327785511,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5374285986386367,
CF2017_OSE 29,0.5394151172542286,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,0.5472516683294957,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,0.5346331100613025,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5437148457451355,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5421235737782882,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),0.5404912727057644,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5374683989715259,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.5392189206031524,
TM2022_S2.12h.B,,
RN2012_L15,0.5413549267629868,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5351531215121161,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.54062843925847,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5358720072815103,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.5404443464054554,
CK2022_5 200-1,0.5406496799323863,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5391089327626172,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5417605431685126,
AH2018_SILAC_MR_1_X,0.5401070106304086,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,0.5426238797555906,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5380261643682764,
AH2018_SILAC_3_C,0.5437179138133301,
EJN2021_5_Rest_Ins,0.539330557248504,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5416188944798854,
CK2022_4 16-1,0.5472719657896865,
AS2011_Ratio H/L,0.5391168812486875,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.5397798635730947,
AS2011_Ratio H/L Inhi_2_3,0.5373388476463515,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5452110764803164,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,0.5394727076691588,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,0.5417800087314517,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,0.5379382325710962,
KTGR2014_Ratio-AA 30 mins,0.5329987101853938,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.5397482440520269,
KBE2022_Log2_Ex_9_T,0.5483139626145777,
AH2018_SILAC_IT_2_N,0.5444783612496252,
AH2018_SILAC_IT_1_X,0.5436680663898171,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5342622756396265,
WZ2023_Pe_025_20min,0.5326037159305367,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,0.5458523909916037,
AH2018_LFQ_2_N,0.5449621058943658,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5451701729417603,
RN2012_H06,0.540222443126977,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),0.5539155315834278,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.544593281760372,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,0.5730318384270142,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5427136502071994,
WZ2023_Su_025_10min,0.5410344616790612,
AH2018_LFQ_IT_4_X,0.5436889270842471,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5417109526848506,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.5392706692105513,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,0.1180218748621104
LG2023_GSK3α-2_intensity,0.5379155880059612,
EP2017_Pervanadate R#1 log2 ratio,0.53581717023386,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5547750785335017,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.53901880494889,
LY2019_P7+,0.5399466473922346,
EP2017_Untreated R#1 normalized log2 ratio,0.5337415130125495,
RN2012_L10,0.535631362945855,
PG2020_Intensity 4h_C,0.535087875995399,
EP2017_Mitotic R#3 normalized log2 ratio,0.534835738006716,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5410408075823144,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5439572283933758,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,0.5450677289702287,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,0.5436173857095706,
KBE2022_Log2_Ex_6_U,0.5356408523177791,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,0.53568303092067,
CR2017_Ratio Replicate 1.1,0.5404238195970547,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5423780143858904,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5329856454860521,
GF2025_P9_Sph,0.5374919799605866,
CK2022_6 200-1,0.5407310895226265,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5380946135980496,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,0.5392498581519614,
PG2020_Intensity 2h_D,0.536033926837941,
EP2017_Untreated R#3 normalized log2 ratio,0.542385192523307,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5404229882717595,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5403482548138753,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.533742072504653,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),0.5157654788501181,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5429774513293272,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),0.5435773330673531,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.5484465405455973,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,0.5580470926066136,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.5393790746044919,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5416616439436018,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5444811439834897,
PG2020_Intensity CT_C,0.5323679579338602,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.5388583136696038,
EP2017_Untreated R#3 log2 ratio,0.5423500782137641,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,0.5423263023464501,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5388513131994438,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.5440840880158867,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.528378055219595,
AS2011_Ratio H/L Normalized Inhi_2,0.5425869916059622,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5429161372099683,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),0.5414255535046683,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5390172146990333,
YA2020_Reporter_intensity_Normal_No.2,0.5376218308798344,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,0.5428294508932416,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,0.5293145926823388,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5389257913678659,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.546500843428158,
CK2022_2 16-1,0.5473728747414929,
RAM2015_Log2 B,0.5458729877047624,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.5397335819144223,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.5382845569552948,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,0.5373388476463515,
DL2023_24h-3,0.5431340401903023,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.5309386529770433,
WZ2023_Su_025_30min,0.5358958285340626,
AH2018_LFQ_4_N,0.5426728227941778,
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,0.5135899891845318,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.5440224207369376,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,0.5455778861855182,
HH2022_Reporter intensity 7,0.5379236722320588,
AH2018_SILAC_M_1_X,0.5443400027253764,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,0.5452259708580743,
LY2019_P6+,0.529611102795897,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5422992489793353,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,0.5582114313966594,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),0.5399685521295091,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,0.5333305041415033,
AS2011_Ratio H/L Inhi_1,0.5318602173617534,
AS2011_Ratio H/L Normalized RNAi_1_2,0.5610401933771102,
AH2018_TMTMS3_2_C,0.5367780611098741,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5417473996589707,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5433824772016863,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,0.5513430663232085,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,0.5411770198216649,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5456265481805308,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5389727710359874,
AH2018_LFQ_2_X,0.5455711088070075,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,0.5326756469568162,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5480701804664599,
GF2025_P3_Sph,0.5412266526799965,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5439839432681921,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,0.5423204027567665,
AH2018_SILAC_IT_1_N,0.5445198491341144,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,0.5429125449088561,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5339903353164371,
ZQ2022_N1,,
LY2019_P6-,0.5297454510281865,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,0.5418940105496587,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5405191325705418,
AH2018_LFQ_3_N,0.5402829933439862,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.541125539214237,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.5406165890876706,
AS2011_Ratio H/L Normalized Inhi_1,0.5319713195512333,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.5370312611998523,
CK2022_7 40-1,0.5377875701642064,
AS2011_Ratio H/L Inhi_1_3,0.5369139380450401,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,0.5507193155048087,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5341008176071963,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.5371040721427691,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5372736151727354,
WZ2023_Su_025_20min,0.5433835331963159,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5396610099530625,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,0.5342716859931388,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.5387967965956202,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5398156571890506,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.537781274820575,
PG2020_Intensity 10h_D,0.5284235234084433,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5469601783137249,
EJN2021_4_Ex_Ins,0.5391683637168732,
AS2011_Ratio H/L Normalized by Protein,0.5135899891845318,
EJN2021_1_Ex_Ins,0.5386823596317742,
EP2017_Pervanadate R#3 log2 ratio,0.5370568147962493,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5368591311620251,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.5420839914313021,
AH2018_LFQ_M_4_C,0.5549913583248371,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,0.5369139380450401,
DL2023_12h-1,0.5459695457212446,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5337678570496824,
CK2022_6 40-1,0.538872591781054,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.5322941332726829,
LY2019_P3-,0.5244081770716493,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.5400268152046234,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5372350449337554,
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.5390922561953788,
AST2020_Control.1,0.5413338567746812,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5460993412565682,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,0.5482085399055927,
GF2025_P10_Adh,0.54101899838634,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.5421155820189308,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5472033183661213,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5379405120764983,
HS2024_8_I_N2,0.5421426864722191,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5444155978322557,
LY2019_P8+,0.5449915995980256,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,0.5110248850760735,
AH2018_LFQ_M_4_X,0.5489011779337508,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,0.544068553352921,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,0.07833182259285827
KBE2022_Log2_Ex_28_U,0.5421976103420263,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5430680392242595,
LY2019_P2-,0.5364509872390573,
AH2018_LFQ_IT_1_X,0.5441912143825115,
JJ2018_Ratio H/L normalized pP3___1,0.5369877387065731,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5400773947703557,
AST2020_Control.2,0.5412544131283772,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.5404650857676563,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,0.5284034500246113,
HS2024_3_I_T1,0.5401486950728944,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5446699152782787,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.5416570308826226,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.537947110260136,
AH2018_TMTMS3_3_N,0.5392420879286821,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5433506688435392,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5323335815854497,
KBE2022_Log2_Ex_36_T,0.5384250980281126,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5423275162122777,
KS2014_Intensity C2,0.5487575490627653,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5412944915240663,
CK2022_9 200-1,0.5428809600980882,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5431812540379006,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5404098467069234,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5373580750198063,
HS2024_3_I_T3,0.5505342234690963,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,0.5439278348929819,
KS2014_Intensity E15_4,0.5486569590771894,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.5404857801534505,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5418031774027894,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5337341120934774,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5397984148530467,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.5331179360806404,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5367551085214037,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),0.5509079033372853,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.5383359004729353,
AH2018_SILAC_MR_2_C,0.5470229214019815,
LATM2013_Log2 Ratio (Medium/Light) Forward,0.5421527423145198,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.5393426912411459,
JJ2018_Ratio H/M normalized___1,0.5381544053113934,
RCJD2014_15min_2,0.5377372526141688,
AS2011_Ratio H/L_2,0.5479711138727564,
AS2011_Ratio H/L Normalized,0.5279055428115094,
RN2012_H03,0.5361761661725678,
HS2024_5_B_N2,0.5447193379615749,
HS2024_5_I_N1,0.5446802421648751,
HS2024_6_I_N1,0.5417947394750997,
AR2021_KD 48h,0.5366370772489797,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.5404981390155505,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5386011880729397,
KBE2022_Log2_Ex_29_U,0.5476814833235899,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.5498867276198142,
AH2018_LFQ_IT_4_N,0.5436222262191129,
CK2022_15 200-1,0.5429227252941929,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.538175920576674,
JJ2018_Ratio M/L normalized pP3___1,0.5375169448758373,
KBE2022_Log2_Ex_34_T,0.5454913963180051,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5452450279104963,
LATM2013_Log2 Ratio (Light/Medium) Reverse,0.5356884044876102,
CK2022_2 200-1,0.5452276685842435,
AS2011_Ratio H/L Protein RNAi_2,0.5574514206149055,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5444327092829188,
RN2012_H01,0.5414533121356597,
KTGR2014_Ratio-Rapa 2 mins,0.5582091818629586,
EJN2021_2_Rest_Basal,0.539840012095941,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,0.5407039673104542,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5359338962900108,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.5378995889946877,
KBE2022_Log2_Ex_44_U,0.5394014323443871,
WZ2023_Pe_010_20min,0.5397956492209286,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5525074503313077,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5369480179744669,
KS2014_Intensity C1,0.5377270595333689,
FSO2013_Ratio H/M normalized Rep3___1,0.5389139319906373,
AH2018_SILAC_M_3_C,0.5437436114405596,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,0.5396811043376483,
AH2018_SILAC_M_2_C,0.5429666089350657,
AH2018_SILAC_M_2_X,0.5430003695860273,
KTGR2014_Ratio-Rapa 15 mins,0.5379535454086388,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5339188180006201,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5428373770811119,
PG2020_Intensity 6h_C,0.5371630456219312,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,0.532398641430961,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.5433839317327274,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5458809625419898,
CK2022_15 16-1,0.5436236708197555,
CK2022_3 16-1,0.5471816059903571,
LY2019_P4-,0.5424591473232895,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5442940474744382,
GF2025_P8_Adh,0.5449466628170269,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5378903758757576,
CK2022_10 16-1,0.5455604479386079,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,0.5345687312446951,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,0.5257327376169267,
EP2017_Mitotic R#1 log2 ratio,0.5300505184412712,
EJN2021_2_Ex_Basal,0.5390752532955573,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),0.5423024156239715,
KTGR2014_Ratio-Rapa 30 mins,0.5492340542653141,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5418768057385227,
AR2021_L41 10 μM,0.5360185845441189,
CF2017_EOC 2,0.5442343361196512,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5437668345177324,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.5472913538600087,
CK2022_6 16-1,0.5427216953509836,
ZX2022_CB treated Replicate 1,0.5312772088431095,
BS2014_Log2(Ratio H/L normalized Rep_3),0.5400350388733801,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5444778031348068,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5476884161870159,
AR2021_L41 1 μM,0.540591196326421,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5472327836612988,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,0.5401184965211121,
ZX2022_Control Replicate 3,0.5313208920807347,
KS2014_Intensity C4,0.5447315934025143,
AS2011_Ratio H/L Inhi_2,0.5427988772122487,
KBE2022_Log2_Ex_18_T,0.5567648836770899,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.5386105537050161,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5514666695409447,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.538660409181523,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5439507540808163,
WZ2023_Pu_025_10min,0.5425060609481275,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,0.5523038330113094,
RCJD2014_10min_3,0.5430186734533154,
FSO2013_Ratio M/L normalized Rep3___1,0.5397905284963684,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5456611971845106,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5431607212834177,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5424405010862694,
KS2014_Intensity C6,0.5386136677628275,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5375904577161221,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.533938784733227,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.5388789280098004,
AH2018_SILAC_IT_2_C,0.5443570094263316,
CK2022_5 40-1,0.5387189680627442,
AH2018_LFQ_3_X,0.5449522160553496,
UK2020_UA_3,,
LY2019_P7-,0.5442142146073017,
GF2025_P5_Adh,0.537877617545634,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5419192237840472,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5462801002540298,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.5452005810453703,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5391389669758058,
PG2020_Intensity CT_B,0.533620655470373,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5425719926937783,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5435836614259213,
AH2018_LFQ_3_C,0.5475953333258328,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5437428919896719,
YA2020_Reporter_intensity_Cancer_No.4,0.5380860626278734,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.5366469542183139,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.5385041278336994,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.5379739247046047,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5439931230594895,
AST2020_anti-CD3+PDL2,0.5411525487462733,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.5411189675311829,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5308008915355772,
AH2018_TMTMS2_1_X,0.5472700191042389,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,0.5377347949891873,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,0.5610401933771102,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.5388654923268016,
HS2024_6_I_N2,0.5347829070712877,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.5349873552436955,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5429946327269747,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.5441674718889327,
PG2020_Intensity 10h_B,0.5295158789183836,
AH2018_TMTMS3_1_X,0.53884350455275,
CF2017_FTE 14,0.5448972528012278,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5365933643807794,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.5445133266854212,
EP2017_Untreated R#2 normalized log2 ratio,0.5354774425198978,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5384896040475144,
HS2024_5_I_N2,0.5465688248313623,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5336237484335623,
AS2011_Ratio H/L Normalized RNAi_2_1,0.5423204027567665,
